Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Design Corp. (IMDZ) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immune Design Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1437786.
Total stock buying since 2014: $61,950,887.
Total stock sales since 2014: $27,975,785.
Total stock option exercises since 2014: $26,200.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 0 | $0 | 25,466 | $40,258 | 0 | $0 |
| 2018 | 0 | $0 | 917,945 | $1,720,780 | 0 | $0 |
| 2017 | 5,577,000 | $23,060,268 | 17,542 | $156,359 | 10,000 | $13,100 |
| 2016 | 1,641,500 | $10,260,255 | 60,000 | $389,390 | 0 | $0 |
| 2015 | 38,000 | $971,000 | 721,899 | $18,168,974 | 10,000 | $13,100 |
| 2014 | 2,304,947 | $27,659,364 | 625,002 | $7,500,024 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-01 | 0 | $0 | 25,466 | $40,258 | 0 | $0 |
| 2018-12 | 0 | $0 | 902,000 | $1,654,268 | 0 | $0 |
| 2018-01 | 0 | $0 | 15,945 | $66,512 | 0 | $0 |
| 2017-11 | 50,000 | $225,000 | 0 | $0 | 0 | $0 |
| 2017-10 | 5,477,000 | $22,469,942 | 0 | $0 | 0 | $0 |
| 2017-08 | 0 | $0 | 10,000 | $116,010 | 10,000 | $13,100 |
| 2017-07 | 20,000 | $182,751 | 0 | $0 | 0 | $0 |
| 2017-05 | 30,000 | $182,575 | 0 | $0 | 0 | $0 |
| 2017-01 | 0 | $0 | 7,542 | $40,349 | 0 | $0 |
| 2016-12 | 0 | $0 | 60,000 | $389,390 | 0 | $0 |
| 2016-09 | 1,640,000 | $10,250,000 | 0 | $0 | 0 | $0 |
| 2016-07 | 1,500 | $10,255 | 0 | $0 | 0 | $0 |
| 2015-11 | 0 | $0 | 5,000 | $100,000 | 5,000 | $6,550 |
| 2015-09 | 0 | $0 | 5,000 | $80,955 | 5,000 | $6,550 |
| 2015-08 | 3,000 | $43,500 | 0 | $0 | 0 | $0 |
| 2015-05 | 0 | $0 | 177,607 | $3,886,041 | 0 | $0 |
| 2015-04 | 35,000 | $927,500 | 252,575 | $6,814,022 | 0 | $0 |
| 2015-03 | 0 | $0 | 281,717 | $7,287,956 | 0 | $0 |
| 2014-07 | 2,304,947 | $27,659,364 | 625,002 | $7,500,024 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-07 | Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) | Sale | 3,522 | 1.57 | 5,536 |
| 2019-01-07 | Paya Carlos V (President and CEO) | Sale | 13,014 | 1.58 | 20,588 |
| 2019-01-07 | Brady Stephen R (EVP, Strategy & Finance) | Sale | 5,516 | 1.58 | 8,720 |
| 2019-01-07 | Ter Meulen Jan Henrik (Chief Scientific Officer) | Sale | 3,414 | 1.59 | 5,414 |
| 2018-12-04 | Lampert Mark N | Sale | 902,000 | 1.83 | 1,654,268 |
| 2018-01-05 | Paya Carlos V (President and CEO) | Sale | 7,970 | 4.17 | 33,250 |
| 2018-01-05 | Brady Stephen R (EVP, Strategy & Finance) | Sale | 3,328 | 4.17 | 13,884 |
| 2018-01-05 | Ter Meulen Jan Henrik (Chief Scientific Officer) | Sale | 1,986 | 4.17 | 8,281 |
| 2018-01-05 | Gombotz Wayne (Chief Development Officer) | Sale | 1,986 | 4.17 | 8,281 |
| 2018-01-04 | Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) | Sale | 675 | 4.17 | 2,816 |
| 2017-11-02 | Coleman Lewis W (Director) | Buy | 50,000 | 4.50 | 225,000 |
| 2017-10-30 | Berger Franklin M (Director) | Buy | 25,000 | 4.58 | 114,375 |
| 2017-10-27 | Kutzkey Tim (10% Owner) | Buy | 2,681,000 | 4.10 | 10,992,099 |
| 2017-10-27 | Svennilson Peter (Director) | Buy | 2,681,000 | 4.10 | 10,992,099 |
| 2017-10-27 | Coleman Lewis W (Director) | Buy | 65,000 | 4.07 | 264,745 |
| 2017-10-25 | Berger Franklin M (Director) | Buy | 25,000 | 4.26 | 106,624 |
| 2017-08-01 | Gombotz Wayne (Chief Development Officer) | Sale | 10,000 | 11.60 | 116,010 |
| 2017-08-01 | Gombotz Wayne (Chief Development Officer) | Option Ex | 10,000 | 1.31 | 13,100 |
| 2017-07-11 | Coleman Lewis W (Director) | Buy | 2,000 | 9.32 | 18,650 |
| 2017-07-10 | Coleman Lewis W (Director) | Buy | 10,000 | 8.99 | 89,949 |
| 2017-07-07 | Coleman Lewis W (Director) | Buy | 4,000 | 9.15 | 36,600 |
| 2017-07-06 | Coleman Lewis W (Director) | Buy | 4,000 | 9.39 | 37,552 |
| 2017-05-10 | Guthart Leo | Buy | 5,000 | 6.14 | 30,700 |
| 2017-05-09 | Guthart Leo | Buy | 25,000 | 6.08 | 151,875 |
| 2017-01-04 | Paya Carlos V (President and CEO) | Sale | 3,940 | 5.35 | 21,079 |
| 2017-01-04 | Brady Stephen R (EVP, Strategy & Finance) | Sale | 1,642 | 5.35 | 8,784 |
| 2017-01-04 | Ter Meulen Jan Henrik (Chief Scientific Officer) | Sale | 980 | 5.35 | 5,243 |
| 2017-01-04 | Gombotz Wayne (Chief Development Officer) | Sale | 980 | 5.35 | 5,243 |
| 2016-12-22 | Coleman Lewis W (Director) | Sale | 10,000 | 6.20 | 62,040 |
| 2016-12-16 | Berger Franklin M (Director) | Sale | 50,000 | 6.55 | 327,350 |
| 2016-09-20 | Svennilson Peter (Director) | Buy | 800,000 | 6.25 | 5,000,000 |
| 2016-09-20 | Coleman Lewis W (Director) | Buy | 40,000 | 6.25 | 250,000 |
| 2016-09-20 | Goeddel David V (10% Owner) | Buy | 800,000 | 6.25 | 5,000,000 |
| 2016-07-15 | Brady Stephen R (EVP, Strategy & Finance) | Buy | 1,500 | 6.84 | 10,255 |
| 2015-11-23 | Gombotz Wayne (Chief Development Officer) | Sale | 5,000 | 20.00 | 100,000 |
| 2015-11-23 | Gombotz Wayne (Chief Development Officer) | Option Ex | 5,000 | 1.31 | 6,550 |
| 2015-09-14 | Gombotz Wayne (Chief Development Officer) | Sale | 5,000 | 16.19 | 80,955 |
| 2015-09-14 | Gombotz Wayne (Chief Development Officer) | Option Ex | 5,000 | 1.31 | 6,550 |
| 2015-08-25 | Coleman Lewis W (Director) | Buy | 3,000 | 14.50 | 43,500 |
| 2015-05-12 | Schreiber Alain (10% Owner) | Sale | 177,607 | 21.88 | 3,886,041 |
| 2015-04-24 | Schreiber Alain (10% Owner) | Sale | 25,000 | 26.64 | 666,000 |
| 2015-04-23 | Schreiber Alain (10% Owner) | Sale | 32,643 | 27.00 | 881,197 |
| 2015-04-22 | Schreiber Alain (10% Owner) | Sale | 25,249 | 26.56 | 670,613 |
| 2015-04-21 | Berger Franklin M (Director) | Buy | 25,000 | 26.50 | 662,500 |
| 2015-04-21 | Schreiber Alain (10% Owner) | Sale | 14,167 | 26.35 | 373,300 |
| 2015-04-21 | Coleman Lewis W (Director) | Buy | 10,000 | 26.50 | 265,000 |
| 2015-04-20 | Schreiber Alain (10% Owner) | Sale | 12,792 | 26.44 | 338,220 |
| 2015-04-17 | Schreiber Alain (10% Owner) | Sale | 18,861 | 26.67 | 503,022 |
| 2015-04-16 | Schreiber Alain (10% Owner) | Sale | 100 | 26.75 | 2,675 |
| 2015-04-15 | Schreiber Alain (10% Owner) | Sale | 40,000 | 28.87 | 1,154,800 |
| 2015-04-14 | Schreiber Alain (10% Owner) | Sale | 13,814 | 27.26 | 376,569 |
| 2015-04-07 | Schreiber Alain (10% Owner) | Sale | 3,600 | 26.55 | 95,580 |
| 2015-04-06 | Schreiber Alain (10% Owner) | Sale | 3,895 | 26.88 | 104,697 |
| 2015-04-01 | Schreiber Alain (10% Owner) | Sale | 62,454 | 26.38 | 1,647,349 |
| 2015-03-25 | Schreiber Alain (10% Owner) | Sale | 4,956 | 27.56 | 136,587 |
| 2015-03-24 | Schreiber Alain (10% Owner) | Sale | 13,200 | 27.67 | 365,244 |
| 2015-03-23 | Schreiber Alain (10% Owner) | Sale | 5,000 | 27.78 | 138,900 |
| 2015-03-20 | Schreiber Alain (10% Owner) | Sale | 9,464 | 27.88 | 263,837 |
| 2015-03-19 | Schreiber Alain (10% Owner) | Sale | 30,000 | 27.81 | 834,300 |
| 2015-03-18 | Schreiber Alain (10% Owner) | Sale | 20,000 | 26.90 | 538,040 |
| 2015-03-17 | Schreiber Alain (10% Owner) | Sale | 20,000 | 25.94 | 518,800 |
| 2015-03-16 | Schreiber Alain (10% Owner) | Sale | 10,309 | 25.43 | 262,157 |
| 2015-03-12 | Schreiber Alain (10% Owner) | Sale | 94,199 | 24.94 | 2,349,323 |
| 2015-03-11 | Schreiber Alain (10% Owner) | Sale | 29,000 | 25.02 | 725,580 |
| 2015-03-10 | Schreiber Alain (10% Owner) | Sale | 6,143 | 24.65 | 151,424 |
| 2015-03-09 | Schreiber Alain (10% Owner) | Sale | 32,300 | 25.61 | 827,203 |
| 2015-03-06 | Schreiber Alain (10% Owner) | Sale | 1,146 | 25.01 | 28,661 |
| 2015-03-05 | Schreiber Alain (10% Owner) | Sale | 6,000 | 24.65 | 147,900 |
| 2014-07-29 | Svennilson Peter (Director) | Buy | 399,016 | 12.00 | 4,788,192 |
| 2014-07-29 | Versant Side Fund Iii, L.p. (10% Owner) | Buy | 233,333 | 12.00 | 2,799,996 |
| 2014-07-29 | Versant Side Fund Iii, L.p. (10% Owner) | Sale | 208,334 | 12.00 | 2,500,008 |
| 2014-07-29 | Berger Franklin M (Director) | Buy | 50,000 | 12.00 | 600,000 |
| 2014-07-29 | Atwood Brian G (Director) | Buy | 233,333 | 12.00 | 2,799,996 |
| 2014-07-29 | Atwood Brian G (Director) | Sale | 208,334 | 12.00 | 2,500,008 |
| 2014-07-29 | Penhoet Edward (Director) | Buy | 299,559 | 12.00 | 3,594,708 |
| 2014-07-29 | Champsi Farah (10% Owner) | Buy | 299,559 | 12.00 | 3,594,708 |
| 2014-07-29 | Goeddel David V (10% Owner) | Buy | 399,016 | 12.00 | 4,788,192 |
| 2014-07-29 | Moorin Jay (10% Owner) | Buy | 391,131 | 12.00 | 4,693,572 |
| 2014-07-29 | Moorin Jay (10% Owner) | Sale | 208,334 | 12.00 | 2,500,008 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMDZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Design Corp. (symbol IMDZ, CIK number 1437786) see the Securities and Exchange Commission (SEC) website.